Savara Pharmaceuticals
SVRA
#7068
Rank
โ‚ฌ0.40 B
Marketcap
2,38ย โ‚ฌ
Share price
1.22%
Change (1 day)
-53.06%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -โ‚ฌ75.87 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ52.37 Million a decrease over its 2022 earnings that were of -โ‚ฌ36.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ75.87 Million44.88%
2023 -โ‚ฌ52.37 Million43.38%
2022 -โ‚ฌ36.53 Million-11.31%
2021 -โ‚ฌ41.18 Million-13.3%
2020 -โ‚ฌ47.5 Million-36.53%
2019 -โ‚ฌ74.84 Million13.76%
2018 -โ‚ฌ65.79 Million105.54%
2017 -โ‚ฌ32.01 Million34.11%
2016 -โ‚ฌ23.87 Million-37.43%
2015 -โ‚ฌ38.15 Million38.81%
2014 -โ‚ฌ27.48 Million33.62%
2013 -โ‚ฌ20.57 Million38.49%
2012 -โ‚ฌ14.85 Million24.59%
2011 -โ‚ฌ11.92 Million-36.5%
2010 -โ‚ฌ18.77 Million-3.14%
2009 -โ‚ฌ19.38 Million-23.28%
2008 -โ‚ฌ25.26 Million8.52%
2007 -โ‚ฌ23.28 Million-34.14%
2006 -โ‚ฌ35.34 Million184.43%
2005 -โ‚ฌ12.43 Million90.75%
2004 -โ‚ฌ6.52 Million190.35%
2003 -โ‚ฌ2.25 Million11.64%
2002 -โ‚ฌ2.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ17.39 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.12 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA